LDH-IN-3
LDH-IN-3 (compound E38) is an inhibitor of LDH, promising protective agent for ischemic nerve damage in the eye and brain. LDH-IN-3 acts its function via HO-1/SIRT1 pathway.[1].
Product Specifications
UNSPSC
12352005
Target
Lactate Dehydrogenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ldh-in-3.html
Smiles
O=C1[C@@]2(N3CCC[C@]3([H])C(C4=CC=CC(O)=C4)C2C(C5=CC=C(O)C(OC)=C5)=O)C6=CC=CC7=CC=CC1=C67
Molecular Formula
C32H27NO5
Molecular Weight
505.56
References & Citations
[1]Wu J, et al. Design, green synthesis, and anti-glutamate damage screening of chalcone derivatives with spiro-heterocyclic structures as potential anti-ischemic brain and eye damage agents. Bioorg Chem. 2024 Dec;153:107870.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-H971210-250MG 250 mg
6-Hydroxy 2,4,5-Triaminopyrimidine Sulfate
Sign In for Pricing
View Details 
BNC942046-500 1x 500 µL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401201-100 1x 100 µL
Neurofilament (H+L) (RT-97 + NR-4), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 